Meridia Attorneys New York, New Jersey, Philadelphia
Meridia Linked with Increase of Heart Attack and Stroke
The weight loss drug Meridia, also known as sibutramine, has been removed from the market in the United States and Canada because of increased risk of serious heart problems. A post-release, long-term scientific study found the drug was associated with a significant increase in risk of major adverse cardiovascular events. If you or a loved one has taken this drug and suffered heart or other health problems, contact the Meridia attorneys at Locks Law Firm, serving Pennsylvania, New Jersey, and New York areas.
Meridia is a dangerous pharmaceutical intended for weight loss and metabolic maintenance for obese individuals. Use of Meridia to stimulate weight loss has been controversial since before it was first approved by the Food and Drug Administration (FDA) in November of 1997. At that time, an FDA advisory panel initially recommended against approval of the drug.
Back to top
The Sibutramine Cardiovascular Outcomes Trial
The FDA requested that the drug’s manufacturer, Abbott Laboratories, cease selling and marketing Meridia after a long-term scientific study found that the health risks significantly outweighed the modest benefits. The trial, known as the Sibutramine Cardiovascular Outcomes Trial (SCOUT), was a randomized, double-blind, placebo-controlled international research trial. The SCOUT trial demonstrated a 16 percent increase in risk of major adverse cardiovascular events such as heart attack, stroke, resuscitation after cardiac arrest, and cardiovascular death in patients taking Meridia, compared to patients taking a placebo. The trial took place over a period of more than 6 years, from January 2003 to March 2009 in Europe, Latin America, and Australia. On average, those taking Meridia lost only about 2.5 percentage points of their weight more than those taking the placebo. According to Dr. John Jenkins, director of the FDA’s office of new drugs, there were no patients for whom the benefits of Meridia outweighed its risks.
Despite the clear safety concerns which were brought to light by the SCOUT trial, Meridia remained on the market in the United States for more than 8 months after it was removed from European markets.
Back to top
The Meridia attorneys at Locks Law Firm, serving all Pennsylvania, New York, and New Jersey areas, would like to discuss your legal rights if you or a family member have taken Meridia and have suffered any of the following adverse effects:
- Heart attack
Depending on your circumstances, you could be eligible to recover financial compensation to pay for any medical bills associated with care you received for your injuries, as well as for loss of wages, diminished earning capacity, and pain and suffering
Contact Our Meridia Attorneys
Locks Law Firm is currently accepting claims from individuals who have been harmed from taking the Meridia diet pill. Contact the attorneys at Locks Law, with locations in Pennsylvania, New Jersey, and New York, to schedule a free, personal consultation.
Back to top
Contact a Pennsylvania, New York, or New Jersey Meridia lawyer to schedule a free consultation and case evaluation.